E-mail a Wiley Online Library Link

Hedwig E. Deubzer, Marie C. Schier, Ina Oehme, Marco Lodrini, Bernard Haendler, Anette Sommer and Olaf Witt HDAC11 is a novel drug target in carcinomas International Journal of Cancer 132

Version of Record online: 25 OCT 2012 | DOI: 10.1002/ijc.27876

What's new?

Histone deacetylase (HDAC) enzymes influence the regulation of numerous cellular processes, and their inhibition by small molecules has been shown to provide benefits against multiple cancer types. Here, HDAC11, a recently identified member of the HDAC family, was found to play an important role in the control of proliferation and survival pathways in several carcinoma cell lines. The high incidence of the tumors represented suggests that HDAC11 could be a valuable drug target in oncology.

Complete the form below and we will send an e-mail message containing a link to the selected article on your behalf

Required = Required Field